肠胃舒治疗脓毒症胃肠功能障碍25例疗效观察  

Clinical observation of 25 cases of gastrointestinal dysfunction treated by Changweishu in patients with sepsis

作　　者：陈分乔[1] 成立[1] 高海运 吴丽娟[1] 张贺[1] 许文忠[1] 梅建强[1] 

机构地区：[1]河北省中医院,石家庄050011

出　　处：《中国中医基础医学杂志》2016年第11期1564-1565,共2页JOURNAL OF BASIC CHINESE MEDICINE

基　　金：河北省科学技术研究与发展计划项目(08276101D-36)

摘　　要：目的:观察肠胃舒治疗脓毒症胃肠功能障碍的临床疗效。方法:50位观察病例随机数字表法分为对照组和肠胃舒组各25例。对照组给予西医常规治疗,肠胃舒组给予肠胃舒联合西医常规治疗。治疗7 d后,比较2组病人APACHEⅡ评分、胃肠功能障碍评分及MODS发生率和病死率。结果:治疗后2组病人的APACHEⅡ评分、胃肠功能障碍评分均降低,但肠胃舒组降低程度更加明显,肠胃舒组病人的MODS发生率和病死率均低于对照组。结论:肠胃舒能够改善脓毒症胃肠功能障碍患者的胃肠功能状态,降低MODS发生率和病死率,改善患者预后,为临床治疗提供新的方法。Objective： To observe the clinical effect of Changweishu in the treatment of gastrointestinal dysfunction in patients with sepsis. Method： 50 cases of sepsis gastrointestinal dysfunction were randomly divided into control group, 25 cases and 25 cases of Changweishu group, the control group was given routine treatment of Western medicine, Changweishu group was treated with Changweishu combined with conventional western medicine treatment. After7 days treatment, compare the APACHE Ⅱ score, gastrointestinal dysfunction score and the incidence of MODS and mortality between two groups of patients. Results： after treatment, the APACHE Ⅱ score, gastrointestinal dysfunction score of the two groups decreased, but Changweishu group decreased more obvious; the MODS rate and mortality rate of Changweishu group were lower than those of the control group; the total effective rate of Changweishu group is higher than that of the control group. Conclusion： Changweishu can improve the gastrointestinal function of patients with sepsis, reduce the incidence of MODS and mortality, improve the prognosis, and provide a new method for clinical treatment.

关 键 词：肠胃舒 脓毒症 胃肠功能障碍 

分 类 号：R256.3[医药卫生—中医内科学]